Indegene Share Price
Small Cap | Service | NSE: INDGN | BSE: 544172
₹524.20 
-0.15 (-0.03 %)
Last Updated: 06 Mar 2025 04:01 PM
BEARISH
Overview
Open (₹) 530.50
High (₹) 531.60
Low (₹) 523.55
Prev. Close (₹) 524.35
Volume 4,203
VWAP (₹) 508.43
ROCE (%) 26.13
Industry P/E 41.77
TTM P/E 32.68
P/B Ratio 8.18
Market Cap (₹) Cr.12,592.72
Dividend Yield (%)--
EPS (₹) 15.07
ROE23.41%
Sales Growth (%) 12.29
Profit Growth (%)26.53
Day Range
531.60531.60
52 Week Range
468.90736.60
Historical Returns
Returns (6M)
-21.39 %
Returns (1Y)
-8.14 %
Returns (3Y)
-8.14 %
Returns (5Y)
-8.14 %
Returns (6M)
-21.39 %
Returns (1Y)
-8.14 %
Returns (3Y)
-8.14 %
Returns (5Y)
-8.14 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Company with (25.90%) TTM EPS Growth
- Company with Low Debt
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Company with 25.90% positive TTM EPS growth
- Increasing Annual Revenue for Past 2 Years
- Growth in Net Profit Margin (QoQ)
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
BEARISHRSI 27.13
MFI 9.49
ATR 24.48
Commodity Channel Index -149.53
ROC125 -10.06
ROC21 -14.22
Williams %R -88.74
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 522.51 | 530.48 | 542.21 | 510.78 | 502.81 | 491.08 | 483.11 |
| Week Ago | 564.60 | 574.30 | 584.80 | 554.10 | 544.40 | 533.90 | 524.20 |
| Month Ago | 622.81 | 639.48 | 659.61 | 602.68 | 586.01 | 565.88 | 549.21 |
EMA & SMA
524.20
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 535.18
9 Day 550.63
10 Day 550.89
12 Day 562.51
14 Day 569.83
20 Day 582.01
26 Day 592.99
50 Day 602.68
100 Day 628.34
200 Day 607.45
Deals & Announcements
Bulk and Block Deals
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 27 Dec, 2024 | Manish Gupta | Acquisition | ₹599.19 | 17,000 | BSE |
| 23 Dec, 2024 | Sanjay Suresh Parikh | Acquisition | ₹606.52 | 16,500 | BSE |
| 23 Dec, 2024 | Rajesh Bhaskaran Nair | Acquisition | ₹598.26 | 25,000 | BSE |
| 18 Dec, 2024 | Rajesh Bhaskaran Nair | Acquisition | ₹595.81 | 1,00,000 | BSE |
| 05 Dec, 2024 | Viveksheel A. Ghai | Disposal | ₹627.64 | 20,000 | BSE |
| 28 Sept, 2024 | Suhas Prabhu | Disposal | ₹672.69 | 620 | BSE |
| 28 Sept, 2024 | Suhas Prabhu | Disposal | ₹669.40 | 49,380 | BSE |
Corporate Actions
No corporate actions available.
Announcements
| Date | Source | Detail |
|---|---|---|
| 24 Feb, 2025 | NSE India | INDEGENE LIMITED has informed the Exchange regarding Allotment of Securities |
| 24 Feb, 2025 | BSE India | Allotment of shares under RSU Plan 2020 and ESOP Plan 2020 |
| 24 Feb, 2025 | NSE India | Indegene Limited has informed the Exchange regarding ''Intimation of outcome of resolution passed by Circulation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.''. |
| 24 Feb, 2025 | BSE India | Pursuant to Regulation 30 of the SEBI LODR Regulations, 2015, enclosed herewith is a press release dated February 24, 2025, titled ''Indegene Launches Cortex, A Fit-For- Purpose Generative AI platform, Verticalized For The Life Sciences Industry''. |
| 24 Feb, 2025 | NSE India | Indegene Limited has informed the Exchange regarding a press release dated February 24, 2025, titled "" Indegene Launches Cortex, A Fit-For-Purpose Generative AI Platform, Verticalized For The Life Sciences Industry."". |
| 20 Feb, 2025 | BSE India | Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be meeting Investors / Analysts . |
| 20 Feb, 2025 | NSE India | Indegene Limited has informed the Exchange about Schedule of meet |
| 20 Feb, 2025 | BSE India | Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be meeting 1x1(In Person) Investors / Analysts on 25th February 2025 from 9:00 AM IST in Mumbai. |
| 20 Feb, 2025 | NSE India | Indegene Limited has informed the Exchange about Schedule of meet. |
| 18 Feb, 2025 | BSE India | Pursuant to Regulation 30 of the SEBILODR Regulations, 2015, we hereby inform you that the following resolutions of Board of Directors of Indegene Limited is scheduled to be circulated on Friday, February 21, 2025:\r\n\r\n1. To allot shares under RSU 2020 plan - with bonus element.\r\n2.To allot shares under ESOP 2020 plan - without bonus element. |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results & Others | To consider other business matters. | 28 Jan, 2025 | 30 Jan, 2025 |
| Quarterly Results | -- | 23 Oct, 2024 | 28 Oct, 2024 |
| Quarterly Results | -- | 26 Jul, 2024 | 01 Aug, 2024 |
| Audited Results | -- | 23 May, 2024 | 29 May, 2024 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | May, 2024 |
|---|
About Indegene
Indegene is a Public Limited Listed company incorporated on 16/10/1998 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is U73100KA1998PLC102040 and registration number is 102040. Currently company belongs to the Industry of Services - Others. Company’s Total Operating Revenue is Rs. 1045.60 Cr. and Equity Capital is Rs. 44.40 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1998
Managing Director
-- --
NSE Symbol
INDGN
Indegene Management
| Name | Designation |
|---|---|
| Mr. Manish Gupta | Chairman & CEO |
| Dr. Sanjay Suresh Parikh | Executive Director |
| Dr. Rajesh Bhaskaran Nair | Non Executive Director |
| Mr. Krishnamurthy Venugopala Tenneti | Ind. Non-Executive Director |
| Dr. Ashish Gupta | Ind. Non-Executive Director |
| Mr. Jairaj Manohar Purandare | Ind. Non-Executive Director |
| Mr. Parvin Udhyavara Bhadya Rao | Ind. Non-Executive Director |
| Dr. Georgia Nikolakopoulou Papathomas | Ind. Non-Executive Director |
| Mr. Neeraj Bharadwaj | Non Exe. & Nominee Director |
| Mr. Mark Francis Dzialga | Non Exe. & Nominee Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| CRISIL | ₹40,850.67 | ₹4,549.40  ₹4,439.55(2.47%) | ₹3,665.100 - ₹5,921.100 |
| CDSL | ₹37,150.80 | ₹1,175.90 ₹1,139.00(3.24%) | ₹811.000 - ₹1,989.800 |
| Inter.Gemmo | ₹25,350.49 | ₹332.25 ₹325.60(2.04%) | ₹454.550 - ₹610.400 |
| Indegene | ₹14,403.99 | ₹526.30 ₹524.40(0.36%) | ₹468.900 - ₹736.600 |
| Quess Corp | ₹9,815.59 | ₹635.60 ₹627.25(1.33%) | ₹460.000 - ₹875.000 |
FAQs on Indegene
What is the share price of Indegene?
The share price of Indegene on 06 Mar, 2025 is ₹ 524.20.
What is 52W high and 52W low share price of Indegene?
The highest and lowest 52W share prices of Indegene are ₹ 736.600 and ₹ 468.900
What is the market cap of Indegene?
The market capitalization of Indegene as of 06 Mar, 2025 is ₹ 12,592.72 Crores
What is the P/E ratio of Indegene?
The current P/E ratio of Indegene as of 06 Mar, 2025 is 41.77
What is the PB ratio of Indegene?
The PB ratio of Indegene as of 06 Mar, 2025 is 8.18
Top Gainers
948IHFL26I
IBHFL NCD186
₹845.00
₹705.00 (0.20%)
GREAVESCOT
Greaves
₹281.85
₹234.90 (0.20%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.20%)
CAPRO
Caprola.Chem
₹62.40
₹52.00 (0.20%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.10%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.10%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0.00%)